Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6,696 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hemodynamic Profiles of Shock in Patients With COVID-19.
Hollenberg SM, Safi L, Parrillo JE, Fata M, Klinkhammer B, Gayed N, Glotzer T, Go RC, Gourna-Paleoudis E, Landers D, Jamal S, Shah N, Shah R, Tancredi J, Turi ZG. Hollenberg SM, et al. Among authors: shah r, shah n. Am J Cardiol. 2021 Aug 15;153:135-139. doi: 10.1016/j.amjcard.2021.05.029. Epub 2021 May 26. Am J Cardiol. 2021. PMID: 34167784 Free PMC article.
Methylprednisolone and 60 Days in Hospital Survival in Coronavirus Disease 2019 Pneumonia.
Go RC, Shah R, Nyirenda T, Oe Y, Sarfraz K, Panthappattu JJ, Philip L, Bheeman C, Shah N, Shah S, Dar S, Hung S, Rahman W, Im H, Marafelias M, Omidvari K, Pradhan A, Sadikot S, Rose KM, Sperber SJ, Josephs J. Go RC, et al. Among authors: shah r, shah s, shah n. Crit Care Explor. 2021 Jul 19;3(7):e0493. doi: 10.1097/CCE.0000000000000493. eCollection 2021 Jul. Crit Care Explor. 2021. PMID: 34291223 Free PMC article.
Heart failure with reduced ejection fraction due topolycythemia vera.
Zaman MO, Kim K, Yousafzai OK, Umer M, Jones RG, Shah R, Kim B. Zaman MO, et al. Among authors: shah r. Oxf Med Case Reports. 2021 Oct 26;2021(10):omab104. doi: 10.1093/omcr/omab104. eCollection 2021 Oct. Oxf Med Case Reports. 2021. PMID: 34729202 Free PMC article.
Capillary blood self-collection for high-throughput proteomics.
El-Sabawi B, Huang S, Tanriverdi K, Perry AS, Amancherla K, Jackson N, Hulsey J, Freedman JE, Shah R, Lindman BR. El-Sabawi B, et al. Among authors: shah r. Proteomics. 2024 May 24:e2300607. doi: 10.1002/pmic.202300607. Online ahead of print. Proteomics. 2024. PMID: 38783781
Over-The-Counter Hearing Aids: Are They Safe and Effective?
Shah R, Wilkins SG, Panth N, Tyagi S, Dunn H, Bell MD, Norgaard S, Guyer E, Schwartz N. Shah R, et al. Otolaryngol Head Neck Surg. 2024 May 20. doi: 10.1002/ohn.817. Online ahead of print. Otolaryngol Head Neck Surg. 2024. PMID: 38769863
In situ gelling systems for ocular drug delivery.
Ahmed B, Jaiswal S, Naryal S, Shah RM, Alany RG, Kaur IP. Ahmed B, et al. Among authors: shah rm. J Control Release. 2024 May 18:S0168-3659(24)00315-8. doi: 10.1016/j.jconrel.2024.05.031. Online ahead of print. J Control Release. 2024. PMID: 38768662 Review.
Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial.
Coutts SB, Ankolekar S, Appireddy R, Arenillas JF, Assis Z, Bailey P, Barber PA, Bazan R, Buck BH, Butcher KS, Camden MC, Campbell B, Casaubon LK, Catanese L, Chatterjee K, Choi PMC, Clarke B, Dowlatshahi D, Ferrari J, Field TS, Ganesh A, Ghia D, Goyal M, Greisenegger S, Halse O, Horn M, Hunter G, Imoukhuede O, Kelly PJ, Kennedy J, Kenney C, Kleinig TJ, Krishnan K, Lima F, Mandzia JL, Marko M, Martins SO, Medvedev G, Menon BK, Mishra SM, Molina C, Moussaddy A, Muir KW, Parsons MW, Penn AMW, Pille A, Pontes-Neto OM, Roffe C, Serena J, Simister R, Singh N, Spratt N, Strbian D, Tham CH, Wiggam MI, Williams DJ, Willmot MR, Wu T, Yu AYX, Zachariah G, Zafar A, Zerna C, Hill MD; TEMPO-2 investigators. Coutts SB, et al. Lancet. 2024 May 16:S0140-6736(24)00921-8. doi: 10.1016/S0140-6736(24)00921-8. Online ahead of print. Lancet. 2024. PMID: 38768626
Early on-treatment assessment of T-cells, cytokines and tumor DNA with adaptively-dosed nivolumab + ipilimumab: final results from the phase 2 ADAPT-IT study.
Smithy JW, Kalvin HL, Ehrich FD, Shah R, Adamow M, Raber V, Maher CA, Kleman J, McIntyre DAG, Shoushtari AN, Betof Warner A, Callahan MK, Momtaz P, Eton O, Nair S, Wolchok JD, Chapman PB, Berger MF, Panageas KS, Postow MA. Smithy JW, et al. Among authors: shah r. Clin Cancer Res. 2024 May 20. doi: 10.1158/1078-0432.CCR-23-3643. Online ahead of print. Clin Cancer Res. 2024. PMID: 38767650
6,696 results